Federal grants to Xylyx Bio, Inc.
Xylyx Bio, Inc. in Brooklyn, New York received $6.3 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cardiovascular Diseases Research, with $3.7 million. In fiscal 2025 it was awarded $3.2 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$6.3 million
- Awards4
- Awarded in FY 2025$3.2 million
- Largest award$2.4 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $297,924 |
| FY 2022 | 1 | $950,532 |
| FY 2023 | 1 | $1.1 million |
| FY 2024 | 2 | $665,624 |
| FY 2025 | 3 | $3.2 million |
Programs that fund Xylyx Bio, Inc.
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 2 | $3.7 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $1.3 million |
| Cancer Biology Research | 1 | $1.3 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $6.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Lung fibrosis modeling and compound testing platform using fibrotic lung ecm that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development - project abstract xylyx is developing a pulmonary fibrosis disease modeling and anti-fibrotic compound | Cardiovascular Diseases Research | August 31, 2021 | $2.4 million |
| Liver fibrosis cell-based assay platform: integrating patient-derived fibrotic liver ecm with primary stellate cells, kupffer cells, and hepatocytes to accelerate anti-fibrotic drug development - project abstract xylyx is developing engineered human liver fibrotic lesions as a predictive cell-based | Diabetes, Digestive, and Kidney Diseases Extramural Research | August 23, 2024 | $1.3 million |
| Translational development and clinical evaluation of a bioengineered human lung graft for clinical transplantation - project abstract xylyx bio, in collaboration with leading lung transplant physician-scientists at vanderbilt university medical center (VUMC), is advancing the development of inspirex | Cardiovascular Diseases Research | September 5, 2025 | $1.3 million |
| Multi-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ecms to accelerate anti-metastatic drug development - project abstract xylyx is developing a predictive multi-organ metastatic breast cancer cell-based a | Cancer Biology Research | June 6, 2024 | $1.3 million |
Questions people ask
How much federal grant money does Xylyx Bio, Inc. get?
$6.3 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Xylyx Bio, Inc. the most?
The Department of Health and Human Services, with $6.3 million in 4 awards.
What is Xylyx Bio, Inc.'s largest federal grant?
$2.4 million under Cardiovascular Diseases Research, with its first action in the period on August 31, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Xylyx Bio, Inc.?
Its largest are Cardiovascular Diseases Research, Diabetes, Digestive, and Kidney Diseases Extramural Research and Cancer Biology Research.
Other grant recipients in Brooklyn
- City of New York Board of Education
- Yeled V'Yalda Early Childhood Center Inc.
- Sunset Park Health Council, Inc.
- The Research Foundation for the State University of New York
- Catholic Charities Neighborhood Services, Inc
- United Academy Inc
- Yeshiva Kehilath Yakov Inc
- New York City School Bus Umbrella Services Inc
Largest federal grant recipients in New York · Federal grants in New York